BioGenex Introduces eFISHiency System

Fremont, Calif.-based BioGenex has launched the integrated eFISHiency System for the evaluation of solid tumors and hematological malignancies.

According to the company, the device pinpoints chromosomal aberrations, brings processing time down to less than 30 minutes and can complete 10 FISH protocols simultaneously.

The system includes probes and visualization kits for FFPE or cell samples, and features detection systems and automation. — Anisa Jibrell